𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The sulphonylurea glibenclamide inhibits multidrug resistance protein (MRP1) activity in human lung cancer cells

✍ Scribed by Léa Payen; Laurence Delugin; Arnaud Courtois; Yolande Trinquart; André Guillouzo; Olivier Fardel


Book ID
110005521
Publisher
Nature Publishing Group
Year
2001
Tongue
English
Weight
158 KB
Volume
132
Category
Article
ISSN
0007-1188

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Expression of the multidrug resistance-a
✍ Walter Berger; Leonilla Elbling; Erich Hauptmann; Michael Micksche 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 224 KB 👁 2 views

Human non-small-cell lung cancer (NSCLC) is considered to be a chemotherapy-refractory malignancy. The underlying mechanisms remain rather obscure. The multidrug resistanceassociated protein (MRP), mediating a multidrug resistance (MDR) phenotype, has been reported to be overexpressed in several dru